Sirius Investors

TNDM Financial Statements & Analysis

Complete financial statements for TNDM including income statement, balance sheet, and cash flow statement. Analyze TNDM's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

Financial Health Score

Financial Health Score

78
Good
Poor (0-40)Neutral (40-60)Good (60-100)

Income Statement

Revenue
25.7%
Net Income
56.9%
Gross Margin
5.9%
Operating Margin
66.2%

Balance Sheet

Current Ratio
-23.4%
Debt to Equity
35.8%
Asset Turnover
23.8%

Cash Flow

Operating Cash Flow
176.2%
Net Cash Flow
109.1%
Free Cash Flow
106.0%
Cash Flow to Debt
166.8%

Income Statement Comparison

Revenue & Net Income

Period Comparison

Metric20232024ChangeImpact
Revenue747.72M940.20M25.7%
Gross Profit367.69M489.57M33.1%
Operating Income-233230000-9912700057.5%
Net Income-222611000-9602500056.9%
EPS-3.43-1.4757.1%
EBITDA-194657000-9912700049.1%
Gross Margin49.17%52.07%5.9%
Operating Margin-31.19%-10.54%66.2%
Net Income Margin-29.77%-10.21%65.7%
R&D Expenses169.67M198.88M17.2%

Income Statement Full Table

Metric20242023202220212020
Revenue940.20M747.72M801.22M702.80M498.83M
Gross Profit489.57M367.69M412.99M376.21M260.52M
Operating Income-99127000-233230000-618090008.81M-7957000
Net Income-96025000-222611000-9459400015.57M-34382000
EPS-1.47-3.43-1.470.25-0.56
EBITDA-99127000-194657000-7231400036.50M-13026000
Gross Margin52.07%49.17%51.54%53.53%52.23%
Operating Margin-10.54%-31.19%-7.71%1.25%-1.60%
Net Income Margin-10.21%-29.77%-11.81%2.21%-6.89%
R&D Expenses198.88M169.67M139.11M92.05M63.57M

Our detailed financial analysis helps investors understand TNDM's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track TNDM's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.